Mast cells in allergic diseases and mastocytosis.
Mast cells with their stores of vasoactive and chemotactic mediators are central to the pathogenesis of allergic diseases. The cross-linking of receptorbound IgE molecules on the surface of mast cells initiates a complex chain of events, including calcium ion influx, phospholipid methylation and turnover and cyclic nucleotide metabolism, ultimately resulting in the release of mediators of immediate hypersensitivity. These mast cell mediators are important in smooth muscle reactivity, in the recruitment of eosinophilic and neutrophilic leukocytes and in the generation of secondary chemical mediators. Histologic evidence of mast cell degranulation, biochemical evidence of mast cell mediators in blood and tissues and clinical evidence of signs and symptoms reproducible by these mediators have strongly supported the crucial role of mast cells in asthma, urticaria, anaphylaxis, rhinitis and mastocytosis. Because of their unique location at host environment interfaces, mast cells may both participate in allergic diseases and promote homeostasis.
D000707:Anaphylaxis / Q000276:immunology; D000799:Angioedema / Q000276:immunology; D001249:Asthma / Q000276:immunology; D002630:Chemotactic Factors / Q000502:physiology; D000242:Cyclic AMP / Q000032:analysis; D003594:Cytoplasmic Granules / Q000032:analysis; D006801:Humans; D006967:Hypersensitivity / Q000276:immunology*; D007073:Immunoglobulin E / Q000276:immunology; D008407:Mast Cells / Q000201:enzymology / Q000276:immunology* / Q000378:metabolism / Q000502:physiology; D010455:Peptides / Q000502:physiology; D010743:Phospholipids / Q000378:metabolism; D006255:Rhinitis, Allergic, Seasonal / Q000276:immunology; D014581:Urticaria / Q000276:immunology; D014582:Urticaria Pigmentosa / Q000276:immunology*
D002630:Chemotactic Factors; D010455:Peptides; D010743:Phospholipids; D007073:Immunoglobulin E; D000242:Cyclic AMP